Bone Sarcoma
Showing 1 - 25 of >10,000
Bone Sarcoma Trial in Memphis (behavioral, device, other, drug)
Recruiting
- Bone Sarcoma
- Cognitive Behavior Therapy
- +4 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Feb 24, 2023
Soft Tissue Sarcoma, Bone Sarcoma, Unresectable Soft Tissue Sarcoma Trial in Iowa City (Ascorbate, Gemcitabine)
Not yet recruiting
- Soft Tissue Sarcoma
- +5 more
-
Iowa City, IowaUniversity of Iowa Hospitals & Clinics
Sep 16, 2022
Soft Tissue Sarcoma, Bone Sarcoma Trial in Houston (Cyclophosphamide, attIL2-T cells)
Not yet recruiting
- Soft Tissue Sarcoma
- Bone Sarcoma
- Cyclophosphamide
- attIL2-T cells
-
Houston, TexasM D Anderson Cancer Center
Nov 10, 2022
Sarcoma, Malignant Mesenchymoma, Sarcoma of Bone and Connective Tissue Trial in Heidelberg
Recruiting
- Sarcoma
- +2 more
-
Heidelberg, Baden-Württemberg, GermanyNational Center for Tumour Diseases, University Hospital Heidelb
Nov 21, 2022
Blood Loss, Surgical Trial in Lahore (Tranexamic acid injection, normal saline)
Recruiting
- Blood Loss, Surgical
- Tranexamic acid injection
- normal saline
-
Lahore, Punjab, PakistanShaukat Khanum Memorial Cancer Hospital & Research Center
Jun 22, 2022
Sarcoma, Soft Tissue Sarcoma, Bone Sarcoma Trial in Boston (Aspirin 325mg, Enoxaparin 40Mg/0.4mL Prefilled Syringe)
Enrolling by invitation
- Sarcoma
- +6 more
- Aspirin 325mg
- Enoxaparin 40Mg/0.4mL Prefilled Syringe
-
Boston, MassachusettsSantiago Lozano-Calderon
Jan 20, 2023
Osteosarcoma, Bone Tumor, Bone Sarcoma Trial
Not yet recruiting
- Osteosarcoma
- +25 more
- (no location specified)
Aug 24, 2022
Sarcoma, Soft Tissue Sarcoma, Unresectable Soft Tissue Sarcoma Trial in Iowa City (Ascorbate)
Recruiting
- Sarcoma
- +4 more
-
Iowa City, IowaUniversity of Iowa Hospitals & Clinics
Feb 9, 2022
Advanced or Unresectable Locally Advanced Bone and Soft Tissue Sarcoma Trial (fruquintinib, Envafolimab)
Not yet recruiting
- Advanced or Unresectable Locally Advanced Bone and Soft Tissue Sarcoma
- (no location specified)
Jul 10, 2023
Sarcoma, Sarcoma,Soft Tissue, Sarcoma of Bone Trial in Shanghai (Camrelizumab and fluzoparib with concurrent stereotactic body
Recruiting
- Sarcoma
- +2 more
- Camrelizumab and fluzoparib with concurrent stereotactic body radiotherapy (SBRT)
-
Shanghai, Shanghai, ChinaRuijin Hospital, Shanghai Jiao Tong University, School of Medici
Oct 3, 2023
Bone Sarcoma, Soft Tissue Sarcoma, Pulmonary Metastases Trial in Toronto (Doxorubicin)
Active, not recruiting
- Bone Sarcoma
- +2 more
-
Toronto, CanadaPrincess Margaret Cancer Centre
Apr 8, 2022
Early Psychiatric Referral on Mental Health and Quality of Life
Recruiting
- Sarcoma
- +2 more
- referral to the Memorial Sloan-Kettering Cancer Center (MSK) Department of Psychiatry and Behavioral Sciences.
-
Basking Ridge, New Jersey
- +7 more
Nov 10, 2023
Sarcoma Trial in Beijing (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))
Recruiting
- Sarcoma
- Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)
-
Beijing, ChinaPeking University People's Hospital
Nov 6, 2023
Effectiveness, Sexuality Trial in Zhengzhou (Lenvatinib mesylate capsule)
Not yet recruiting
- Effectiveness
- Sexuality
- Lenvatinib mesylate capsule
-
Zhengzhou, Henan, ChinaDepartment of Bone and Soft Tissue ,Henan Cancer Hospital
Jan 31, 2023
Metastatic Bone Sarcoma, Metastatic Malignant Tumor in the Lung, Metastatic Soft Tissue Sarcoma Trial in Buffalo (Cisplatin,
Recruiting
- Metastatic Bone Sarcoma
- +5 more
- Cisplatin
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jan 24, 2023
Bone Sarcoma, Osteosarcoma, Ewing Sarcoma Trial in France (Treatment by Regorafenib, Treatment by Placebo)
Recruiting
- Bone Sarcoma
- +6 more
- Treatment by Regorafenib
- Treatment by Placebo
-
Besançon, France
- +15 more
Aug 18, 2022
Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma Trial in Providence (Gemcitabine, 9-ING-41,
Withdrawn
- Soft Tissue Sarcoma
- +12 more
- Gemcitabine
- +2 more
-
Providence, Rhode Island
- +1 more
Nov 30, 2021
Bone Cancer Trial in Villejuif (regorafenib tablet)
Recruiting
- Bone Cancer
- regorafenib tablet
-
Villejuif, Ile De France, FranceGustave Roussy
Apr 13, 2023
Radiation Effects on Bone
Enrolling by invitation
- Soft Tissue Sarcoma Adult
- Control Group
- +3 more
-
Syracuse, New YorkSUNY Upstate Medical University
Oct 31, 2022
Osteosarcoma, Sarcoma, Sarcoma,Soft Tissue Trial in Xi'an (Recombinant oncolytic herpes simplex virus type ? (R130))
Recruiting
- Osteosarcoma
- +3 more
- Recombinant oncolytic herpes simplex virus type Ⅰ (R130)
-
Xi'an, Shaanxi, ChinaXi'an Honghui Hospital
May 8, 2023
Quality of Life of Bone Tumor of Lower Limbs Treated With
Enrolling by invitation
- Sarcoma, Ewing
- +2 more
-
Bologna, ItalyIstituto Ortopedico Rizzoli
Mar 17, 2023
Soft Tissue Sarcoma, Bone Sarcoma Trial in Leuven (Functional outcome, Health related quality of life (HRQoL) assessment)
Active, not recruiting
- Soft Tissue Sarcoma
- Bone Sarcoma
- Functional outcome
- Health related quality of life (HRQoL) assessment
-
Leuven, Vlaams-Brabant, BelgiumUZ Leuven
Oct 15, 2021
Ewing Sarcoma, Ewing Sarcoma of Bone, Ewing Sarcoma of Soft Tissue Trial in United States (FoundationOne Liquid CDx)
Recruiting
- Ewing Sarcoma
- +6 more
- FoundationOne Liquid CDx
-
Los Angeles, California
- +14 more
Oct 5, 2023
Personalized Home Exercise Program in Bone Tumor Undergoing
Recruiting
- Osteosarcoma
- +3 more
-
Bologna, ItalyIstituto Ortopedico Rizzoli
Mar 21, 2023
Sarcoma Trial in Shanghai (MASCT-I,PD1 Antibody,Apatinib)
Active, not recruiting
- Sarcoma
- MASCT-I,PD1 Antibody,Apatinib
-
Shanghai, Shanghai, ChinaShanghai Sixth People's Hospital
Nov 22, 2022